Concepedia

Nazanin Majd

NM

Statistics

Publications

18

Citations

724

H-Index

13

Active since

2005

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Baylor College of Medicine

University of Cincinnati Medical Center

Harvard University

University of North Carolina at Chapel Hill

Nazanin Majd is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and glioblastoma.

Publications per year

2005–2025

18

Publications

18

IMP dehydrogenase-2 drives aberrant nucleolar activity and promotes tumorigenesis in glioblastoma

Satoshi Kofuji, Akiyoshi Hirayama, Alexander Otto Eberhardt et al. · Nature Cell Biology · 2019 · 177 citations · Full text

Medicine, Molecular Biology, Oncology +10

The Lipid Kinase PI5P4Kβ Is an Intracellular GTP Sensor for Metabolism and Tumorigenesis

Kazutaka Sumita, Yu-Hua Lo, Koh Takeuchi et al. · Molecular Cell · 2016 · 83 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14

Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II study

Nazanin Majd, Steven G. Waguespack, Filip Jankú et al. · Journal for ImmunoTherapy of Cancer · 2020 · 77 citations · Full text

Medicine, Oncology, Pharmacology +17

A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma

John de Groot, Martina Ott, Jun Wei et al. · CNS Oncology · 2022 · 76 citations · Full text

Medicine, Oncology, Pharmacology +17

Inhibition of neuronal apoptosis by the cyclin‐dependent kinase inhibitor GW8510: Identification of 3′ substituted indolones as a scaffold for the development of neuroprotective drugs

Kyle Johnson, Li Liu, Nazanin Majd et al. · Journal of Neurochemistry · 2005 · 57 citations

Medicine, Neuroscience, Pharmacology +17

1–5 of 18